Flexible solid oral dosage forms of medicines are ideal for children.
理想的儿童药物为灵活的固体口服剂型。
Objective To introduce FDA's biowaiver policy for IR solid oral dosage forms.
目的介绍FDA关于普通口服固体制剂生物等效豁免的相关政策。
Most oral dosage forms of FP had low bioavailability because FP could hardly dissolve.
FP的口服制剂中,大多存在溶出难和生物利用度低的问题。
应用推荐